“Base Molecular Resonance™ Technologies cutting-edge discovery not only transcends boundaries but also redefines the very essence of our approach to healthcare, security, and military safety…”

Robbie Callaway former Chairman and founding Board Member, National Center for Missing & Exploited Children.

“Base Molecular Resonance™ Technologies disruptive innovation stands as a sentinel, fortifying the mission of law enforcement with unprecedented capabilities.”

John F. Clark former Director, United States Marshals Service

“…The advent of BMRT’s groundbreaking technology marks a pivotal moment in our collective defense. In this unique discovery, we find a shield for our borders, a guardian of our liberties, and a sentinel against emerging threats.”

Regina Schofield former Assistant Attorney General of the United States

“…This changes everything. From protecting the president, to ensuring the safety of our troops, to the earliest detection of cancer, covid or mad cow disease, the realm of application is endless. This technology is a game-changer for all of us who seek the very best for people everywhere.”

Kenneth Valentine former United States Secret Service

“…This discovery can safeguard lives, uphold justice, and build stronger, more resilient communities across America.”

William G. Gross former Commissioner, Boston Police Department

“…This patented technology holds a transformative power that has the potential to impact humanity in ways we have yet to fully comprehend.”

Johnny L. Hughes former U.S. Marshal, District of Maryland, United States Marshals Service

“…The technology being introduced by Base Molecular Resonance™ Technologies will serve as a catalyst for a revolution in our understanding of science…”

Vincent J. Truant Founder & former CEO, Matrix Ventures LLC

“…we stand on the precipice of a revolutionary era in cancer detection, where technology becomes a beacon of hope. BMRT’s groundbreaking innovation signifies a quantum leap toward early intervention, empowering us to rewrite the narrative of cancer care.”

Baron Fulk Director, Global Manufacturing and Supply Chain

BASE MOLECULAR RESONANCE™

TECHNOLOGIES

Our breakthrough in quantum physics involving particle interaction at the subatomic level results in a groundbreaking patented technology that can detect every element of the periodic table and up to 200 types of cancers and other diseases.

Since securing a groundbreaking patent in November 2022, we now have an additional 16 patents pending in 2024.

“Base Molecular Resonance™ Technologies cutting-edge discovery not only transcends boundaries but also redefines the very essence of our approach to healthcare, security, and military safety…”

Robbie Callaway former CEO, Technology Investors Inc.

“Base Molecular Resonance™ Technologies disruptive innovation stands as a sentinel, fortifying the mission of law enforcement with unprecedented capabilities.”

John F. Clark former Director, United States Marshals Service

“…The advent of BMRT’s groundbreaking technology marks a pivotal moment in our collective defense. In this unique discovery, we find a shield for our borders, a guardian of our liberties, and a sentinel against emerging threats.”

Regina Schofield former Assistant Attorney General of the United States

“…This changes everything. From protecting the president, to ensuring the safety of our troops, to the earliest detection of cancer, covid or mad cow disease, the realm of application is endless. This technology is a game-changer for all of us who seek the very best for people everywhere.”

Kenneth Valentine former United States Secret Service

“…This discovery can safeguard lives, uphold justice, and build stronger, more resilient communities across America.”

William G. Gross former Commissioner, Boston Police Department

“…This patented technology holds a transformative power that has the potential to impact humanity in ways we have yet to fully comprehend.”

Johnny L. Hughes former U.S. Marshal, District of Maryland, United States Marshals Service

“…The technology being introduced by Base Molecular Resonance™ Technologies will serve as a catalyst for a revolution in our understanding of science…”

Vincent J. Truant CEO, Matrix Ventures LLC

“…we stand on the precipice of a revolutionary era in cancer detection, where technology becomes a beacon of hope. BMRT’s groundbreaking innovation signifies a quantum leap toward early intervention, empowering us to rewrite the narrative of cancer care.”

Baron Fulk Director, Global Manufacturing, Science & Technology, CSL Behring
“Having assessed and evaluated BMRT’s technology, it is clear to me that I have never seen anything quite like it. Indeed, breakthrough technologies which can support every aspect of society are few and far between, leading to multinational success and Nobel prize-worthy impact.”
Professor Philipe B. Wilson, PhD
Associate Pro Vice-Chancellor for Innovation and Knowledge Exchange, and Director of the Centre for Applied Innovation at York St John University in York, England. He also serves as the President-Elect of the Comparative Medicine Council at The Royal Society of Medicine

Different Challenges

Same Solution

Early Detection

Additional Applications

Precious metals exploration    Food safety     Air quality     Water quality     Hazardous waste management    Pharmaceuticals     Oil and gas exploration    Agriculture      Forensics      Drug testing     Clinical diagnostics      Industrial process control      Automotive emissions      Nuclear power plant monitoring      Space exploration      Building inspection      Art restoration      Archaeological research     

Precious Metals Exploration    Food Safety    Environmental Monitoring   Air Quality   Water Quality   Hazardous Waste Management   Pharmaceuticals    Oil and Gas Exploration   Agriculture   Forensics   Drug Testing   Clinical Diagnostics   Industrial Process Control   Automotive Emissions   Nuclear Power Plant Monitoring   Space Exploration    Building Inspection   Groundwater Monitoring    Art Restoration   Archaeological Research